Trader consensus implies an 88.5% probability against a new WHO-declared pandemic in 2026, driven by robust global surveillance from the World Health Organization and Centers for Disease Control and Prevention revealing no novel pathogen with sustained human-to-human transmission across multiple regions. As of mid-April 2026, confirmed outbreaks remain localized—measles cases surpassing 1,700 in the U.S. with 17 clusters, E. coli and Salmonella incidents tied to food sources, and a Streptococcus pneumoniae event in a North Carolina facility—while the SARS-CoV-2 BA.3.2 "Cicada" variant, detected in 23 countries since March, shows immune escape potential but falls short of pandemic thresholds amid ongoing COVID monitoring. Enhanced post-2020 preparedness, including the WHO Pandemic Agreement, bolsters confidence, though experts flag avian influenza and other filoviruses for vigilance; weekly Disease Outbreak News updates will provide key signals.